End-to-end CDMO infrastructure engineered for national healthcare self-sufficiency. 200,000L bioreactor capacity across ISO 5 cleanrooms, fully aligned with SFDA and FDA standards.
Interactive facility overview. Select a system to view technical specifications.
Select a zone on the facility map or choose below.
Interactive floor plan — Jeddah Biomanufacturing Facility. Select a zone to view specifications.
From strategic market entry advisory to full-scale commercial manufacturing, our integrated platform eliminates hand-off friction across the product lifecycle.
Leverage our 200,000L capacity for process development, clinical supply, and commercial-scale production of biologics and vaccines.
Our Innovation Hub advances promising candidates through late-stage R&D, process validation, and regulatory milestones.
Our Advisory platform provides unparalleled local insight, regulatory navigation, and strategic partnership mapping for MENA market entry.
Our inspection-ready Quality Management System is the cryptographic foundation of the Jeddah biomanufacturing hub.
A single, embedded QMS ensures cryptographic data integrity and a complete audit trail from day one.
Proactive, digital quality assurance anticipates regulatory needs, accelerating tech-transfer timelines.
Always inspection-ready for SFDA, FDA, and EMA auditors — providing absolute market certainty.
You don't just get a vendor — you get an end-to-end sovereign partner. Engage us at any stage for a compliant, accelerated pathway to clinical and commercial scale.
Market strategy, regulatory affairs, and stakeholder mapping
R&D, clinical acceleration, and process development
At-scale production, fill-finish, and global supply
Explore how our sovereign biomanufacturing infrastructure can accelerate your pipeline from development to commercial supply.